These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 18090214

  • 1. Study of 99mTc-annexin V uptake in apoptotic cell models of Parkinson's disease.
    Cao W, Huang J, Wu J, Cao G, He Y, Hu D, Sun S, An R, Zhang Y.
    Nucl Med Commun; 2007 Dec; 28(12):895-901. PubMed ID: 18090214
    [Abstract] [Full Text] [Related]

  • 2. Imaging of apoptosis (programmed cell death) with 99mTc annexin V.
    Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW.
    J Nucl Med; 1999 Jan; 40(1):184-91. PubMed ID: 9935075
    [Abstract] [Full Text] [Related]

  • 3. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
    Tait JF, Smith C, Blankenberg FG.
    J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
    Ohtsuki K, Akashi K, Aoka Y, Blankenberg FG, Kopiwoda S, Tait JF, Strauss HW.
    Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
    [Abstract] [Full Text] [Related]

  • 5. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
    Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N.
    J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
    [Abstract] [Full Text] [Related]

  • 6. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
    Lan XL, Zhang YX, He Y, Sun X, An R, Gao ZR, Cao GX.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
    Tokita N, Hasegawa S, Maruyama K, Izumi T, Blankenberg FG, Tait JF, Strauss HW, Nishimura T.
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
    [Abstract] [Full Text] [Related]

  • 8. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.
    Taki J, Higuchi T, Kawashima A, Fukuoka M, Kayano D, Tait JF, Matsunari I, Nakajima K, Kinuya S, Strauss HW.
    J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551
    [Abstract] [Full Text] [Related]

  • 9. Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
    Vermeersch H, Mervillie K, Lahorte C, Loose D, Dierck RA, Steinmetz N, Cuvelier C, Slegers G, Van de Wiele C.
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1016-21. PubMed ID: 15014904
    [Abstract] [Full Text] [Related]

  • 10. Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5.
    Benali K, Louedec L, Azzouna RB, Merceron O, Nassar P, Al Shoukr F, Petiet A, Barbato D, Michel JB, Sarda-Mantel L, Le Guludec D, Rouzet F.
    Mol Imaging; 2014 Jul; 13():. PubMed ID: 25431156
    [Abstract] [Full Text] [Related]

  • 11. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.
    Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA.
    Cancer Biother Radiopharm; 2001 Feb; 16(1):73-83. PubMed ID: 11279800
    [Abstract] [Full Text] [Related]

  • 12. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.
    van de Wiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, Vanderheyden JL, Cuvelier CA, Slegers G, Dierck RA.
    J Clin Oncol; 2003 Sep 15; 21(18):3483-7. PubMed ID: 12972524
    [Abstract] [Full Text] [Related]

  • 13. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K.
    J Nucl Med; 2003 Jun 15; 44(6):947-52. PubMed ID: 12791824
    [Abstract] [Full Text] [Related]

  • 14. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V.
    Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW.
    J Nucl Med; 2004 Sep 15; 45(9):1536-41. PubMed ID: 15347721
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
    Mukherjee A, Kothari K, Tóth G, Szemenyei E, Sarma HD, Környei J, Venkatesh M.
    Nucl Med Biol; 2006 Jul 15; 33(5):635-43. PubMed ID: 16843838
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
    Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N.
    J Nucl Med; 2005 May 15; 46(5):794-9. PubMed ID: 15872353
    [Abstract] [Full Text] [Related]

  • 20. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V.
    Penn DL, Kim C, Zhang K, Mukherjee A, Devakumar D, Jungkind D, Thakur ML.
    Nucl Med Biol; 2010 Jan 15; 37(1):29-34. PubMed ID: 20122665
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.